Can-Fite reports Q2 2026 results and Phase III liver cancer update
Can-Fite reports Q2 2026 financial results and ongoing clinical progress in its pivotal Phase III liver cancer study.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Can-Fite reports Q2 2026 financial results and ongoing clinical progress in its pivotal Phase III liver cancer study.